n | |
---|---|
Gender | |
Male | 110 (26%) |
Female | 321 (74%) |
Race | |
Caucasian | 280 (79%) |
Black | 34 (10%) |
Hispanic | 7 (2%) |
Asian/Pacific Islander | 12 (3%) |
Other | 21 (6%) |
Age (years) at surgery | 45.8 (mean) ± 13.5 (SD) |
Tumor size (cm) | 2.5 (mean) ± 1.6 (SD) (2.2 (median); range, 0.1-10.0 |
Tumor size | |
<1 cm | 39 (11%) |
≥1 cm | 329 (89%) |
Tumor histology | |
Papillary (PTC) | 388 (91%) |
Follicular (FTC) | 20 (5%) |
Both PTC and FTC | 6 (1%) |
Hurthle cell carcinoma (HCC) | 9 (2%) |
Both PTC and HCC | 4 (1%) |
Number of tumor foci | |
1 | 213 (57%) |
≥2 | 161 (43%) |
Thyroid cancer recurrence or persistence | |
Yes | 52 (12%) |
No | 379 (88%) |
Positive disease on follow-up imaging | |
Yes | 33 (9%) |
No | 334 (91%) |
Years after surgery at recurrence | 6.1 (mean) ± 5.6 (SD) 4.3 (median) 0.2-23.2 (range) |